Omalizumab, an anti-IgE antibody, significantly reduces emergency visits in patients with severe persistent asthma: A pooled analysis

Authors :: Howard Fox
William W. Busse
M. Blogg
S. Hedgecock
Eli O. Meltzer
Phillip E. Korenblat
Source :: Journal of Allergy and Clinical Immunology. 115:S76
Publication Year :: 2005
Publisher :: Elsevier BV, 2005.

Subjects :: Pooled analysis
business.industry
Immunology
medicine
Severe persistent asthma
Immunology and Allergy
In patient
Omalizumab
business
Anti-IgE Antibody
medicine.drug

Tools